Small Cell Lung Cancer Pipeline Insight 2025' report provides comprehensive global coverage of pipeline NSCLC therapies in ...

In December 2024, Dovbleron was approved by the NMPA for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC ... to see that Dovbleron ...

It is the only ROS1 TKI with FDA breakthrough therapy designation for locally advanced or metastatic ROS1-positive NSCLC. The FDA has granted priority review to an NDA for taletrectinib in the ...

Jan. 15, 2025 — While most known types of DNA damage are fixed by our cells' in-house DNA repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows.

Jan. 23, 2025 — Researchers have found that a newly developed diet inspired by the eating habits of non-industrialized societies can significantly reduce the risk of ...

Run a brief analysis at the single-cell level, let’s use the common Seurat pipeline. set.seed(12345) sc <- CreateSeuratObject(counts = sc.counts, project = proj.name, meta.data = sc.meta) sc ## An ...

After hours: January 24 at 4:53:33 PM EST Loading Chart for LINE ...

Figure 2: Mechanisms of virus cell-to-cell spread. Fusion of cell plasma membranes can result in the formation of syncytia. In principle, any virus that expresses its fusion machinery on the ...

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

This study is assessing zidesamtinib for the treatment of advanced ROS1-positive non-small cell lung cancer (NSCLC ... with the FDA to pursue a line-agnostic approval for zidesamtinib.